HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Carvedilol Phosphate

HCID 11954344
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
610309-89-2
Standard SMILES
COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12.COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12.O.O=P(O)(O)O.O=P(O)(O)O
InChIKey
LHNYXTULDSJZRB-UHFFFAOYSA-N
Molecular formula
C48H60N4O17P2
Average molar mass
1,027 g/mol
Monoisotopic mass
1,026.34287045

Overview

Carvedilol Phosphate is the phosphate salt form of carvedilol, a racemic mixture and adrenergic blocking agent with antihypertensive activity and devoid of intrinsic sympathomimetic activity. The S enantiomer of carvedilol nonselectively binds to and blocks beta-adrenergic receptors, thereby exerting negative inotropic and chronotropic effects, and leading to a reduction in cardiac output. In addition, both enantiomers of carvedilol bind to and block alpha 1-adrenergic receptors, thereby causing vasodilation and reducing peripheral vascular resistance.

Names & identifiers

Preferred name
Carvedilol Phosphate
IUPAC
bis(1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol);phosphoric acid;hydrate
English name
CARVEDILOL PHOSPHATE
Molecular formula
C24H26N2O4.H2O.H3O4P
Molecular weight
522.488

Names & synonyms

Carvedilol phosphate610309-89-2Carvedilol phosphate hemihydrateCarvedilol dihydrogen phosphate hemihydrateSKF 105517DUNII-EQT531S367EQT531S367SK&F-105517-DSKF-105517D(2RS)-1-(9H-Carbazol-4-yloxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)propan-2-ol phosphate salt (1:1) hemihydrate(2RS)-1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]propan-2-ol phosphate salt (1:1) hemihydrateCOREGCR
Show more names
Carvedilol PHeCarvedilol Phosphate BPCarvedilol Phosphate APICARVEDILOL PHOSPHATE USP/EP/BPBM 14190 (phosphate hemihydrate)1-9H-(Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanolphosphateHemihydrate1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol,phosphoric acid,hydrate
COREGCRCRRefChem:547272-PROPANOL, 1-(9H-CARBAZOL-4-YLOXY)-3-((2-(2-METHOXYPHENOXY)ETHYL)AMINO), PHOSPHATE (SALT), HYDRATE (2:2:1)Coreg CRCarvedilol phosphate hydrateCarvedilol phosphate [USAN]1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol;phosphoric acid;hydrate2-Propanol,1-(9H-carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-,phosphate (salt), hydrate (2:2:1)

Properties

Computed structural properties

Topological polar surface area
308 Ų
Hydrogen bond donors
13
Hydrogen bond acceptors
19
Rotatable bonds
20
Heavy atoms
71
Formal charge
0
Complexity
557

Experimental & physicochemical properties

Human Drugs · 2 items

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Physicochemical properties

storage temp.
-20 °C · Store at -20°C
solubility
Soluble in DMSO
form
Solid
color
White to off-white
NCI Dictionary of Cancer Terms
carvedilol phosphate
FDA UNII
531 S367 · EQT531S367
Symbol(GHS)
7 · GHS07,GHS09
Signal word
Warning
Hazard statements
410 · H410-H317-H400
Precautionary statements
261 · P261-P272-P280-P302+P352-P333+P313-P321-P363-P501-P273-P391-P501-P273-P391-P501

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Warning

H317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin]

P261, P272, P273, P280, P302+P352, P321, P333+P317, P362+P364, P391, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 2 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Hazard Classes and CategoriesSkin Sens. 1 (100%)

Safety data

Signal word
Warning
Symbol(GHS)
GHS07,GHS09
Hazard statements
H410-H317-H400
Precautionary statements
P261-P272-P280-P302+P352-P333+P313-P321-P363-P501-P273-P391-P501-P273-P391-P501

Chemistry & industry

Pharmacology

FDA Pharmacological Classification · 2 items

CARVEDILOL PHOSPHATE

Adrenergic beta2-Antagonists [MoA]; Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]; Adrenergic beta1-Antagonists [MoA]; beta-Adrenergic Blocker [EPC]

Applications

UsesTreatment of congestive heart failure, left ventricular dysfunction following myocardial infarction, and management of hypertension.

Related reactions

6 records
New reaction record
HRID 601725 reaction equation
HRID 601725As product
HRID 916055 reaction equation
HRID 916055As product
HRID 1366866 reaction equation
HRID 1366866As product
HRID 1865348 reaction equation
HRID 1865348As product
HRID 2353398 reaction equation
HRID 2353398As product
HRID 2356839 reaction equation
HRID 2356839As product

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
610309-89-2
PubChem CID
11954344
DTXSID
DTXSID60976535
ChEMBL
CHEMBL1201167
UNII
EQT531S367
EC Number
642-914-8